These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2553230)

  • 1. Nuclear inclusions in oculopharyngeal muscular dystrophy in Quebec.
    Bouchard JP; Gagné F; Tomé FM; Brunet D
    Can J Neurol Sci; 1989 Nov; 16(4):446-50. PubMed ID: 2553230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews.
    Blumen SC; Sadeh M; Korczyn AD; Rouche A; Nisipeanu P; Asherov A; Tomé FM
    Neurology; 1996 May; 46(5):1324-8. PubMed ID: 8628475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of inclusion body myositis-like filaments in oculopharyngeal muscular dystrophy. Ultrastructural study of 10 cases.
    Coquet M; Vital C; Julien J
    Neuropathol Appl Neurobiol; 1990 Oct; 16(5):393-400. PubMed ID: 2175847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial abnormalities in oculopharyngeal muscular dystrophy.
    Pauzner R; Blatt I; Mouallem M; Ben-David E; Farfel Z; Sadeh M
    Muscle Nerve; 1991 Oct; 14(10):947-52. PubMed ID: 1944407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculopharyngeal muscular dystrophy in Italy.
    Meola G; Sansone V; Rotondo G; Tomé FM; Bouchard JP
    Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S53-6. PubMed ID: 9392017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear inclusions in innervated cultured muscle fibers from patients with oculopharyngeal muscular dystrophy.
    Tomé FM; Askanas V; Engel WK; Alvarez RB; Lee CS
    Neurology; 1989 Jul; 39(7):926-32. PubMed ID: 2544827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranuclear inclusions in oculopharyngeal muscular dystrophy contain poly(A) binding protein 2.
    Becher MW; Kotzuk JA; Davis LE; Bear DG
    Ann Neurol; 2000 Nov; 48(5):812-5. PubMed ID: 11079550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculopharyngeal muscular dystrophy: recent ultrastructural evidence for mitochondrial abnormalities.
    Pratt MF; Meyers PK
    Laryngoscope; 1986 Apr; 96(4):368-73. PubMed ID: 3007900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy.
    Tomé FM; Chateau D; Helbling-Leclerc A; Fardeau M
    Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S63-9. PubMed ID: 9392019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premortem examination of the cricopharyngeus muscle in oculopharyngeal muscular dystrophy: inflammatory cells and tubular aggregates--case report.
    Watters MR; Herbers JE
    Mil Med; 1985 Dec; 150(12):686-8. PubMed ID: 3935975
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy.
    Askanas V; Serdaroglu P; Engel WK; Alvarez RB
    Neurosci Lett; 1991 Sep; 130(1):73-6. PubMed ID: 1660975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculopharyngeal muscular dystrophy: clinical and morphological follow-up study reveals mitochondrial alterations and unique nuclear inclusions in a severe autosomal recessive type.
    Schröder JM; Krabbe B; Weis J
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):68-73. PubMed ID: 7770123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear inclusions in oculopharyngeal dystrophy. An ultrastructural study of six cases.
    Coquet M; Vallat JM; Vital C; Fournier M; Barat M; Orgogozo JM; Julien J; Loiseau P
    J Neurol Sci; 1983 Jul; 60(1):151-6. PubMed ID: 6308176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear inclusions in oculopharyngeal dystrophy.
    Tomé FM; Fardeau M
    Acta Neuropathol; 1980; 49(1):85-7. PubMed ID: 6243839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranuclear inclusions in oculopharyngeal dystrophy.
    Smith TW; Chad D
    Muscle Nerve; 1984 May; 7(4):339-40. PubMed ID: 6328293
    [No Abstract]   [Full Text] [Related]  

  • 16. Oculopharyngeal muscular dystrophy: non-French-Canadian pedigrees.
    Creel GB; Giuliani MJ; Lacomis D; Holbach SM
    Muscle Nerve; 1998 Jun; 21(6):816-8. PubMed ID: 9585341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculopharyngeal muscular dystrophy.
    Adamczyk DT; Oshinskie L
    J Am Optom Assoc; 1987 May; 58(5):408-12. PubMed ID: 3584810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oculopharyngeal muscular dystrophy specific intranuclear tubulofilamentous inclusions].
    Uyama E; Uchino M; Ando M; Chateau D; Tomé FM
    Rinsho Shinkeigaku; 1995 Jul; 35(7):817-8. PubMed ID: 8777812
    [No Abstract]   [Full Text] [Related]  

  • 19. Oculopharyngeal muscular dystrophy in Uruguay.
    Medici M; Pizzarossa C; Skuk D; Yorio D; Emmanuelli G; Mesa R
    Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S50-2. PubMed ID: 9392016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
    Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.